vs

Side-by-side financial comparison of SAUL CENTERS, INC. (BFS) and PETMED EXPRESS INC (PETS). Click either name above to swap in a different company.

SAUL CENTERS, INC. is the larger business by last-quarter revenue ($75.1M vs $40.7M, roughly 1.8× PETMED EXPRESS INC). SAUL CENTERS, INC. runs the higher net margin — 8.7% vs -26.0%, a 34.6% gap on every dollar of revenue. On growth, SAUL CENTERS, INC. posted the faster year-over-year revenue change (10.6% vs -23.3%). Over the past eight quarters, SAUL CENTERS, INC.'s revenue compounded faster (6.2% CAGR vs -20.9%).

Saul Centers, Inc. is a self-administered real estate investment trust (REIT) headquartered in the United States. It primarily owns, operates, and develops high-quality shopping centers, mixed-use properties, and multifamily residential assets, with its core portfolio concentrated in the Washington D.C. metropolitan area and other select high-growth U.S. regional markets.

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

BFS vs PETS — Head-to-Head

Bigger by revenue
BFS
BFS
1.8× larger
BFS
$75.1M
$40.7M
PETS
Growing faster (revenue YoY)
BFS
BFS
+33.9% gap
BFS
10.6%
-23.3%
PETS
Higher net margin
BFS
BFS
34.6% more per $
BFS
8.7%
-26.0%
PETS
Faster 2-yr revenue CAGR
BFS
BFS
Annualised
BFS
6.2%
-20.9%
PETS

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
BFS
BFS
PETS
PETS
Revenue
$75.1M
$40.7M
Net Profit
$6.5M
$-10.6M
Gross Margin
23.3%
Operating Margin
65.4%
-25.7%
Net Margin
8.7%
-26.0%
Revenue YoY
10.6%
-23.3%
Net Profit YoY
-19.6%
-1392.6%
EPS (diluted)
$0.15
$-0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BFS
BFS
PETS
PETS
Q4 25
$75.1M
$40.7M
Q3 25
$72.0M
$44.4M
Q2 25
$70.8M
$51.2M
Q1 25
$71.9M
$50.8M
Q4 24
$67.9M
$52.0M
Q3 24
$67.3M
$58.0M
Q2 24
$66.9M
$66.2M
Q1 24
$66.7M
$65.1M
Net Profit
BFS
BFS
PETS
PETS
Q4 25
$6.5M
$-10.6M
Q3 25
$10.5M
$-8.5M
Q2 25
$10.7M
$-34.2M
Q1 25
$9.8M
$-11.6M
Q4 24
$8.1M
$-707.0K
Q3 24
$14.5M
$2.3M
Q2 24
$14.4M
$3.8M
Q1 24
$13.6M
$-5.0M
Gross Margin
BFS
BFS
PETS
PETS
Q4 25
23.3%
Q3 25
28.0%
Q2 25
28.1%
Q1 25
29.9%
Q4 24
31.0%
Q3 24
73.6%
32.3%
Q2 24
74.2%
28.8%
Q1 24
72.8%
29.3%
Operating Margin
BFS
BFS
PETS
PETS
Q4 25
65.4%
-25.7%
Q3 25
69.1%
-18.9%
Q2 25
68.7%
-66.7%
Q1 25
66.5%
-11.9%
Q4 24
82.9%
-0.9%
Q3 24
72.8%
1.0%
Q2 24
75.0%
6.6%
Q1 24
72.4%
-5.9%
Net Margin
BFS
BFS
PETS
PETS
Q4 25
8.7%
-26.0%
Q3 25
14.6%
-19.2%
Q2 25
15.1%
-66.7%
Q1 25
13.6%
-22.9%
Q4 24
11.9%
-1.4%
Q3 24
21.5%
4.0%
Q2 24
21.6%
5.7%
Q1 24
20.4%
-7.7%
EPS (diluted)
BFS
BFS
PETS
PETS
Q4 25
$0.15
$-0.50
Q3 25
$0.32
$-0.41
Q2 25
$0.33
$-1.65
Q1 25
$0.29
$-0.56
Q4 24
$0.22
$-0.03
Q3 24
$0.48
$0.11
Q2 24
$0.48
$0.18
Q1 24
$0.45
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BFS
BFS
PETS
PETS
Cash + ST InvestmentsLiquidity on hand
$8.7M
$26.9M
Total DebtLower is stronger
$468.4M
Stockholders' EquityBook value
$307.8M
$32.8M
Total Assets
$2.2B
$88.0M
Debt / EquityLower = less leverage
1.52×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BFS
BFS
PETS
PETS
Q4 25
$8.7M
$26.9M
Q3 25
$11.8M
$36.1M
Q2 25
$5.3M
$41.1M
Q1 25
$6.5M
$54.7M
Q4 24
$10.3M
$50.1M
Q3 24
$7.2M
$52.0M
Q2 24
$6.9M
$46.0M
Q1 24
$7.1M
$55.3M
Total Debt
BFS
BFS
PETS
PETS
Q4 25
$468.4M
Q3 25
$1.6B
Q2 25
$1.6B
Q1 25
$1.5B
Q4 24
$455.8M
Q3 24
$1.5B
Q2 24
$1.4B
Q1 24
$1.4B
Stockholders' Equity
BFS
BFS
PETS
PETS
Q4 25
$307.8M
$32.8M
Q3 25
$316.6M
$43.1M
Q2 25
$322.4M
$51.5M
Q1 25
$328.4M
$85.1M
Q4 24
$335.8M
$96.2M
Q3 24
$341.8M
$96.4M
Q2 24
$345.7M
$93.5M
Q1 24
$347.1M
$96.7M
Total Assets
BFS
BFS
PETS
PETS
Q4 25
$2.2B
$88.0M
Q3 25
$2.2B
$100.3M
Q2 25
$2.1B
$109.8M
Q1 25
$2.1B
$148.7M
Q4 24
$2.1B
$144.8M
Q3 24
$2.1B
$146.0M
Q2 24
$2.1B
$152.7M
Q1 24
$2.0B
$169.9M
Debt / Equity
BFS
BFS
PETS
PETS
Q4 25
1.52×
Q3 25
5.02×
Q2 25
4.85×
Q1 25
4.70×
Q4 24
1.36×
Q3 24
4.37×
Q2 24
4.17×
Q1 24
4.06×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BFS
BFS
PETS
PETS
Operating Cash FlowLast quarter
$99.8M
$-9.2M
Free Cash FlowOCF − Capex
$-9.2M
FCF MarginFCF / Revenue
-22.7%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
15.35×
TTM Free Cash FlowTrailing 4 quarters
$-23.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BFS
BFS
PETS
PETS
Q4 25
$99.8M
$-9.2M
Q3 25
$20.6M
$-2.2M
Q2 25
$26.6M
$-12.3M
Q1 25
$30.4M
$7.0M
Q4 24
$121.2M
$-1.2M
Q3 24
$26.5M
$7.4M
Q2 24
$32.1M
$-8.5M
Q1 24
$33.8M
$7.1M
Free Cash Flow
BFS
BFS
PETS
PETS
Q4 25
$-9.2M
Q3 25
$-4.8M
Q2 25
$-13.6M
Q1 25
$4.6M
Q4 24
$-1.9M
Q3 24
$-28.3M
$6.1M
Q2 24
$-12.5M
$-9.2M
Q1 24
$-11.7M
$5.9M
FCF Margin
BFS
BFS
PETS
PETS
Q4 25
-22.7%
Q3 25
-10.8%
Q2 25
-26.5%
Q1 25
9.1%
Q4 24
-3.7%
Q3 24
-42.1%
10.6%
Q2 24
-18.7%
-13.9%
Q1 24
-17.6%
9.0%
Capex Intensity
BFS
BFS
PETS
PETS
Q4 25
0.1%
Q3 25
5.9%
Q2 25
2.5%
Q1 25
4.7%
Q4 24
1.5%
Q3 24
81.5%
2.2%
Q2 24
66.7%
1.0%
Q1 24
68.3%
1.9%
Cash Conversion
BFS
BFS
PETS
PETS
Q4 25
15.35×
Q3 25
1.97×
Q2 25
2.48×
Q1 25
3.10×
Q4 24
14.98×
Q3 24
1.83×
3.18×
Q2 24
2.22×
-2.27×
Q1 24
2.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BFS
BFS

Segment breakdown not available.

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

Related Comparisons